UPLOAD Filing
Armata Pharmaceuticals, Inc.
Date: Aug. 15, 2025 · CIK: 0000921114 · Accession: 0000000000-25-008642
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-289585
Letter
Re: Armata Pharmaceuticals, Inc. Registration Statement on Form S-3 Filed August 13, 2025 File No. 333-289585 Dear Deborah L. Birx M.D.:
August 15, 2025
Deborah L. Birx, M.D. Chief Executive Officer Armata Pharmaceuticals, Inc. 5005 McConnell Avenue Los Angeles, California 90066
This is to advise you that we have not reviewed and will not review your registration statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of
Corporation Finance
Office of Life
Sciences
cc: Andrew C. Marmer
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> August 15, 2025 Deborah L. Birx, M.D. Chief Executive Officer Armata Pharmaceuticals, Inc. 5005 McConnell Avenue Los Angeles, California 90066 Re: Armata Pharmaceuticals, Inc. Registration Statement on Form S-3 Filed August 13, 2025 File No. 333-289585 Dear Deborah L. Birx M.D.: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Andrew C. Marmer </TEXT> </DOCUMENT>